{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:56:38Z","timestamp":1787064998252,"version":"build-2736575974"},"reference-count":142,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetes is a complex disorder responsible for the mortality and morbidity of millions of individuals worldwide. Although many approaches have been used to understand and treat diabetes, the role of proteoglycans, in particular heparan sulfate proteoglycans (HSPGs), has only recently received attention. The HSPGs are heterogeneous, highly negatively charged, and are found in all cells primarily attached to the plasma membrane or present in the extracellular matrix (ECM). HSPGs are involved in development, cell migration, signal transduction, hemostasis, inflammation, and antiviral activity, and regulate cytokines, chemokines, growth factors, and enzymes. Hyperglycemia, accompanying diabetes, increases reactive oxygen species and upregulates the enzyme heparanase that degrades HSPGs or affects the synthesis of the HSPGs altering their structure. The modified HSPGs in the endothelium and ECM in the blood vessel wall contribute to the nephropathy, cardiovascular disease, and retinopathy seen in diabetes. Besides the blood vessel, other cells and tissues in the heart, kidney, and eye are affected by diabetes. Although not well understood, the adipose tissue, intestine, and brain also reveal HSPG changes associated with diabetes. Further, HSPGs are significantly involved in protecting the \u03b2 cells of the pancreas from autoimmune destruction and could be a focus of prevention of type I diabetes. In some circumstances, HSPGs may contribute to the pathology of the disease. Understanding the role of HSPGs and how they are modified by diabetes may lead to new treatments as well as preventative measures to reduce the morbidity and mortality associated with this complex condition.<\/jats:p>","DOI":"10.1055\/s-0041-1724118","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T18:39:56Z","timestamp":1617302396000},"page":"261-273","source":"Crossref","is-referenced-by-count":17,"title":["Heparan Sulfate Proteoglycans in Diabetes"],"prefix":"10.1055","volume":"47","author":[{"given":"Linda M.","family":"Hiebert","sequence":"additional","affiliation":[{"name":"Department of Veterinary Biomedical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/joim.12061","article-title":"Pathophysiology of heparan sulphate: many diseases, few drugs","volume":"273","author":"U Lindahl","year":"2013","journal-title":"J Intern Med"},{"issue":"06","key":"ref2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4155\/fmc-2016-0012","article-title":"Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases","volume":"8","author":"S Rivara","year":"2016","journal-title":"Future Med Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-3-642-23056-1_8","article-title":"Heparin and heparan sulfate: analyzing structure and microheterogeneity","volume":"207","author":"Z Shriver","year":"2012","journal-title":"Handb Exp Pharmacol"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.matbio.2013.02.007","article-title":"Unexpected new roles for heparanase in type 1 diabetes and immune gene regulation","volume":"32","author":"C R Parish","year":"2013","journal-title":"Matrix Biol"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/iep.12135","article-title":"Fell-Muir lecture: heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra","volume":"96","author":"J Gallagher","year":"2015","journal-title":"Int J Exp Pathol"},{"issue":"15","key":"ref6","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1111\/febs.14828","article-title":"Structures and interactions of syndecans","volume":"286","author":"F Gondelaud","year":"2019","journal-title":"FEBS J"},{"issue":"20","key":"ref7","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1242\/dev.076398","article-title":"Ectodomain shedding and ADAMs in development","volume":"139","author":"S Weber","year":"2012","journal-title":"Development"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1042\/BJ20070511","article-title":"Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface","volume":"410","author":"A Traister","year":"2008","journal-title":"Biochem J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3389\/fonc.2019.00708","article-title":"The role of glypican-3 in regulating Wnt, YAP, and Hedgehog in liver cancer","volume":"9","author":"A Kolluri","year":"2019","journal-title":"Front Oncol"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1039\/C3IB40199E","article-title":"Shear-induced endothelial NOS activation and remodeling via heparan sulfate, glypican-1, and syndecan-1","volume":"6","author":"E E Ebong","year":"2014","journal-title":"Integr Biol"},{"issue":"07","key":"ref11","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ajpath.2015.03.025","article-title":"Glypican-5 increases susceptibility to nephrotic damage in diabetic kidney","volume":"185","author":"K Okamoto","year":"2015","journal-title":"Am J Pathol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.matbio.2013.08.004","article-title":"Border patrol: insights into the unique role of perlecan\/heparan sulfate proteoglycan 2 at cell and tissue borders","volume":"34","author":"M C Farach-Carson","year":"2014","journal-title":"Matrix Biol"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/genes9110556","article-title":"Modular proteoglycan perlecan\/HSPG2: Mutations, phenotypes, and functions","volume":"9","author":"J R Martinez","year":"2018","journal-title":"Genes (Basel)"},{"issue":"43","key":"ref14","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1021\/bi8013938","article-title":"Diverse cell signaling events modulated by perlecan","volume":"47","author":"J M Whitelock","year":"2008","journal-title":"Biochemistry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.matbio.2016.10.002","article-title":"Collagen XVIII in tissue homeostasis and dysregulation - lessons learned from model organisms and human patients","volume":"57\u201358","author":"R Heljasvaara","year":"2017","journal-title":"Matrix Biol"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.neuint.2012.02.028","article-title":"The role of agrin in synaptic development, plasticity and signaling in the central nervous system","volume":"61","author":"M P Daniels","year":"2012","journal-title":"Neurochem Int"},{"issue":"09","key":"ref17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.yexcr.2012.02.031","article-title":"The glomerular basement membrane","volume":"318","author":"J H Miner","year":"2012","journal-title":"Exp Cell Res"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/molehr\/8.6.566","article-title":"Localization of heparanase in normal and pathological human placenta","volume":"8","author":"R Haimov-Kochman","year":"2002","journal-title":"Mol Hum Reprod"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/jsre.2001.6337","article-title":"Multiple heparanases are expressed in polymorphonuclear cells","volume":"103","author":"M A Kosir","year":"2002","journal-title":"J Surg Res"},{"issue":"09","key":"ref20","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.4049\/jimmunol.172.9.5185","article-title":"Enzymatically quiescent heparanase augments T cell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts","volume":"172","author":"I Sotnikov","year":"2004","journal-title":"J Immunol"},{"issue":"02","key":"ref21","first-page":"112","article-title":"Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation","volume":"12","author":"I Vlodavsky","year":"1992","journal-title":"Invasion Metastasis"},{"issue":"07","key":"ref22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/10525","article-title":"Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis","volume":"5","author":"M D Hulett","year":"1999","journal-title":"Nat Med"},{"issue":"07","key":"ref23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/10518","article-title":"Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis","volume":"5","author":"I Vlodavsky","year":"1999","journal-title":"Nat Med"},{"issue":"03","key":"ref24","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1006\/bbrc.2000.3586","article-title":"Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member","volume":"276","author":"E McKenzie","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"42","key":"ref25","doi-asserted-by":"crossref","first-page":"44084","DOI":"10.1074\/jbc.M402131200","article-title":"Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans","volume":"279","author":"S Gingis-Velitski","year":"2004","journal-title":"J Biol Chem"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.biocel.2006.06.004","article-title":"Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis","volume":"38","author":"N Ilan","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"issue":"48","key":"ref27","doi-asserted-by":"crossref","first-page":"E7808","DOI":"10.1073\/pnas.1611380113","article-title":"Heparanase is required for activation and function of macrophages","volume":"113","author":"L Gutter-Kapon","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"06","key":"ref28","doi-asserted-by":"crossref","first-page":"91R","DOI":"10.1093\/glycob\/11.6.91R","article-title":"Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans","volume":"11","author":"K J Bame","year":"2001","journal-title":"Glycobiology"},{"issue":"05","key":"ref29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.matbio.2013.03.002","article-title":"Involvement of heparanase in atherosclerosis and other vessel wall pathologies","volume":"32","author":"I Vlodavsky","year":"2013","journal-title":"Matrix Biol"},{"issue":"01","key":"ref30","first-page":"a006429","article-title":"Endothelial cell heterogeneity","volume":"2","author":"W C Aird","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"02","key":"ref31","first-page":"H508","article-title":"Permeation of the luminal capillary glycocalyx is determined by hyaluronan","volume":"277","author":"C B Henry","year":"1999","journal-title":"Am J Physiol"},{"issue":"04","key":"ref32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MNH.0b013e32832c9dba","article-title":"Glomerular filtration barrier","volume":"18","author":"B Haraldsson","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"03","key":"ref33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"S Reitsma","year":"2007","journal-title":"Pflugers Arch"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00540-014-1887-6","article-title":"Implications of recent accumulating knowledge about endothelial glycocalyx on anesthetic management","volume":"29","author":"G M Bashandy","year":"2015","journal-title":"J Anesth"},{"issue":"05","key":"ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/694312","article-title":"Modulation of endothelial glycocalyx structure under inflammatory conditions","volume":"2014","author":"H Kol\u00e1lov\u00e1","year":"2014","journal-title":"Mediators Inflamm"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1161\/01.RES.0000101744.47866.D5","article-title":"Heparan sulfate proteoglycan is a mechanosensor on endothelial cells","volume":"93","author":"J A Florian","year":"2003","journal-title":"Circ Res"},{"issue":"07","key":"ref37","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1161\/ATVBAHA.118.310839","article-title":"Endothelial glycocalyx as a shield against diabetic vascular complications: involvement of hyaluronan and hyaluronidases","volume":"38","author":"S Dogn\u00e9","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"09","key":"ref38","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/01.ATV.0000085630.24353.3D","article-title":"Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface","volume":"23","author":"A A Constantinescu","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/SLA.0b013e318226113d","article-title":"A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients","volume":"254","author":"P I Johansson","year":"2011","journal-title":"Ann Surg"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fnmol.2018.00014","article-title":"Heparan sulfate proteoglycans as emerging players in synaptic specificity","volume":"11","author":"G Condomitti","year":"2018","journal-title":"Front Mol Neurosci"},{"issue":"07","key":"ref41","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"A Rawshani","year":"2018","journal-title":"N Engl J Med"},{"issue":"04","key":"ref42","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/ATVBAHA.119.310961","article-title":"Diabetes mellitus and cardiovascular disease: emerging therapeutic approaches","volume":"39","author":"A M Schmidt","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"1479164119896975","DOI":"10.1177\/1479164119896975","article-title":"A comparative study of sulphated polysaccharide effects on advanced glycation end-product uptake and scavenger receptor class A level in macrophages","volume":"17","author":"T Nishinaka","year":"2020","journal-title":"Diabetes Vasc Dis Res"},{"issue":"06","key":"ref44","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"A Goldin","year":"2006","journal-title":"Circulation"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1475-2840-4-12","article-title":"Endothelial cell injury by high glucose and heparanase is prevented by insulin, heparin and basic fibroblast growth factor","volume":"4","author":"J Han","year":"2005","journal-title":"Cardiovasc Diabetol"},{"issue":"07","key":"ref46","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.2337\/diabetes.54.7.2172","article-title":"Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients","volume":"54","author":"J B Maxhimer","year":"2005","journal-title":"Diabetes"},{"issue":"07","key":"ref47","first-page":"927","article-title":"Heparanase upregulation in high glucose-treated endothelial cells is prevented by insulin and heparin","volume":"232","author":"J Han","year":"2007","journal-title":"Exp Biol Med (Maywood)"},{"issue":"04","key":"ref48","doi-asserted-by":"crossref","first-page":"H1108","DOI":"10.1152\/ajpheart.01312.2008","article-title":"Endothelial heparanase secretion after acute hypoinsulinemia is regulated by glucose and fatty acid","volume":"296","author":"F Wang","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/cvr\/cvq051","article-title":"Glucose-induced endothelial heparanase secretion requires cortical and stress actin reorganization","volume":"87","author":"F Wang","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"46","key":"ref50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1475-2840-8-46","article-title":"Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin","volume":"8","author":"J Han","year":"2009","journal-title":"Cardiovasc Diabetol"},{"issue":"04","key":"ref51","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1083\/jcb.148.4.811","article-title":"Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase","volume":"148","author":"M L Fitzgerald","year":"2000","journal-title":"J Cell Biol"},{"issue":"05","key":"ref52","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/bja\/aer269","article-title":"Shedding of the coronary endothelial glycocalyx: effects of hypoxia\/reoxygenation vs ischaemia\/reperfusion","volume":"107","author":"T Annecke","year":"2011","journal-title":"Br J Anaesth"},{"issue":"37","key":"ref53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1475-2840-12-37","article-title":"Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K\/AKT pathway","volume":"12","author":"Q Qin","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11010-011-0804-7","article-title":"Advanced glycation end-products induce heparanase expression in endothelial cells by the receptor for advanced glycation end products and through activation of the FOXO4 transcription factor","volume":"354","author":"X F An","year":"2011","journal-title":"Mol Cell Biochem"},{"issue":"02","key":"ref55","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.atherosclerosis.2010.09.003","article-title":"Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine","volume":"213","author":"A B Baker","year":"2010","journal-title":"Atherosclerosis"},{"issue":"01","key":"ref56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2337\/db11-1024","article-title":"Heparanase is essential for the development of diabetic nephropathy in mice","volume":"61","author":"N Gil","year":"2012","journal-title":"Diabetes"},{"issue":"01","key":"ref57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10719-011-9365-y","article-title":"Heparan sulfate expression is affected by inflammatory stimuli in primary human endothelial cells","volume":"29","author":"T M Reine","year":"2012","journal-title":"Glycoconj J"},{"issue":"21","key":"ref58","doi-asserted-by":"crossref","first-page":"20457","DOI":"10.1074\/jbc.M414546200","article-title":"Identification and characterization of heparin\/heparan sulfate binding domains of the endoglycosidase heparanase","volume":"280","author":"F Levy-Adam","year":"2005","journal-title":"J Biol Chem"},{"issue":"04","key":"ref59","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease","volume":"15","author":"U J Jung","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"04","key":"ref60","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","article-title":"Role of oxidative modifications in atherosclerosis","volume":"84","author":"R Stocker","year":"2004","journal-title":"Physiol Rev"},{"issue":"02","key":"ref61","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"M Y Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"ref62","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.freeradbiomed.2008.03.016","article-title":"Oxidative damage to extracellular matrix and its role in human pathologies","volume":"44","author":"M D Rees","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"03","key":"ref63","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1073\/pnas.81.3.762","article-title":"Characterization of heparan sulfate-proteoglycan of glomerular basement membranes","volume":"81","author":"Y S Kanwar","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1007110700454","article-title":"Influence of glucose on production and N-sulfation of heparan sulfate in cultured adipocyte cells","volume":"213","author":"N Parthasarathy","year":"2000","journal-title":"Mol Cell Biochem"},{"issue":"01","key":"ref65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/002215549804600104","article-title":"Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane","volume":"46","author":"A J Groffen","year":"1998","journal-title":"J Histochem Cytochem"},{"issue":"06","key":"ref66","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1681\/ASN.2004050387","article-title":"Heparan sulfate of perlecan is involved in glomerular filtration","volume":"16","author":"H Morita","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2353\/ajpath.2007.061116","article-title":"Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity","volume":"171","author":"S J Harvey","year":"2007","journal-title":"Am J Pathol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3389\/fphys.2018.01470","article-title":"Novel Insights into the role of glycans in the pathophysiology of glomerular endotheliosis in preeclampsia","volume":"9","author":"M F Galvis-Ram\u00edrez","year":"2018","journal-title":"Front Physiol"},{"issue":"01","key":"ref69","doi-asserted-by":"crossref","first-page":"F111","DOI":"10.1152\/ajprenal.00173.2005","article-title":"Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier","volume":"290","author":"M Jeansson","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"issue":"01","key":"ref70","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3181\/0705-MR-134","article-title":"Diabetic nephropathy: mechanisms of renal disease progression","volume":"233","author":"Y S Kanwar","year":"2008","journal-title":"Exp Biol Med (Maywood)"},{"issue":"01","key":"ref71","doi-asserted-by":"crossref","first-page":"F253","DOI":"10.1152\/ajprenal.00429.2007","article-title":"Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria","volume":"294","author":"J W Celie","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12967-015-0538-5","article-title":"Impact of heparanase on renal fibrosis","volume":"13","author":"V Masola","year":"2015","journal-title":"J Transl Med"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jdiacomp.2016.10.013","article-title":"Significance of urinary glycosaminoglycans\/proteoglycans in the evaluation of type 1 and type 2 diabetes complications","volume":"31","author":"A J Lepedda","year":"2017","journal-title":"J Diabetes Complications"},{"issue":"03","key":"ref74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00398060","article-title":"Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane","volume":"37","author":"J T Tamsma","year":"1994","journal-title":"Diabetologia"},{"issue":"01","key":"ref75","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ki.1992.15","article-title":"A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats","volume":"41","author":"J van den Born","year":"1992","journal-title":"Kidney Int"},{"issue":"03","key":"ref76","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000070156","article-title":"Isolation, identification, and quantitation of urinary glycosaminoglycans","volume":"23","author":"E Y Lee","year":"2003","journal-title":"Am J Nephrol"},{"issue":"03","key":"ref77","doi-asserted-by":"crossref","first-page":"486","DOI":"10.18433\/J3GS3C","article-title":"Diabetes results in structural alteration of chondroitin sulfate in the urine","volume":"16","author":"T Zhao","year":"2013","journal-title":"J Pharm Pharm Sci"},{"issue":"07","key":"ref78","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/glycob\/cwr029","article-title":"Diabetes results in structural alteration of chondroitin sulfate\/dermatan sulfate in the rat kidney: effects on the binding to extracellular matrix components","volume":"21","author":"D Joladarashi","year":"2011","journal-title":"Glycobiology"},{"issue":"12","key":"ref79","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/sj.ki.5001985","article-title":"Increased expression of heparanase in overt diabetic nephropathy","volume":"70","author":"M J van den Hoven","year":"2006","journal-title":"Kidney Int"},{"issue":"02","key":"ref80","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00125-007-0879-6","article-title":"Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy","volume":"51","author":"T J Wijnhoven","year":"2008","journal-title":"Diabetologia"},{"issue":"07","key":"ref81","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1093\/ndt\/gfr732","article-title":"Urinary heparanase activity in patients with type 1 and type 2 diabetes","volume":"27","author":"A L Rops","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"02","key":"ref82","doi-asserted-by":"crossref","first-page":"e17312","DOI":"10.1371\/journal.pone.0017312","article-title":"Heparanase levels are elevated in the urine and plasma of type 2 diabetes patients and associate with blood glucose levels","volume":"6","author":"I Shafat","year":"2011","journal-title":"PLoS One"},{"issue":"09","key":"ref83","doi-asserted-by":"crossref","first-page":"e44076","DOI":"10.1371\/journal.pone.0044076","article-title":"Elevated urine heparanase levels are associated with proteinuria and decreased renal allograft function","volume":"7","author":"I Shafat","year":"2012","journal-title":"PLoS One"},{"issue":"02","key":"ref84","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1523-1755.2000.00858.x","article-title":"Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria","volume":"57","author":"C J Raats","year":"2000","journal-title":"Kidney Int"},{"issue":"04","key":"ref85","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00285287","article-title":"Albuminuria reflects widespread vascular damage. The Steno hypothesis","volume":"32","author":"T Deckert","year":"1989","journal-title":"Diabetologia"},{"issue":"05","key":"ref86","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ng.792","article-title":"Common variation in GPC5 is associated with acquired nephrotic syndrome","volume":"43","author":"K Okamoto","year":"2011","journal-title":"Nat Genet"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/IJNRD.S37883","article-title":"Tubulointerstitial disease in diabetic nephropathy","volume":"7","author":"G Tonolo","year":"2014","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"02","key":"ref88","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1074\/jbc.M111.279836","article-title":"Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells","volume":"287","author":"V Masola","year":"2012","journal-title":"J Biol Chem"},{"issue":"01","key":"ref89","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12933-018-0793-x","article-title":"Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project","volume":"17","author":"M Zhou","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"09","key":"ref90","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/01.ATV.14.9.1445","article-title":"Lipoprotein lipase is produced by cardiac myocytes rather than interstitial cells in human myocardium","volume":"14","author":"K D O'Brien","year":"1994","journal-title":"Arterioscler Thromb"},{"issue":"08","key":"ref91","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2337\/db13-1842","article-title":"Endothelial cell heparanase taken up by cardiomyocytes regulates lipoprotein lipase transfer to the coronary lumen after diabetes","volume":"63","author":"Y Wang","year":"2014","journal-title":"Diabetes"},{"issue":"11","key":"ref92","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1194\/jlr.R018689","article-title":"GPIHBP1, an endothelial cell transporter for lipoprotein lipase","volume":"52","author":"S G Young","year":"2011","journal-title":"J Lipid Res"},{"issue":"03","key":"ref93","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0008-6363(03)00469-3","article-title":"Circulating triglyceride lipolysis facilitates lipoprotein lipase translocation from cardiomyocyte to myocardial endothelial lining","volume":"59","author":"T Pulinilkunnil","year":"2003","journal-title":"Cardiovasc Res"},{"issue":"05","key":"ref94","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/ATVBAHA.113.301309","article-title":"Endothelial heparanase regulates heart metabolism by stimulating lipoprotein lipase secretion from cardiomyocytes","volume":"33","author":"Y Wang","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"01","key":"ref95","doi-asserted-by":"crossref","first-page":"H82","DOI":"10.1152\/ajpheart.00372.2017","article-title":"Dual effects of hyperglycemia on endothelial cells and cardiomyocytes to enhance coronary LPL activity","volume":"314","author":"A P Chiu","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"ref96","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1161\/ATVBAHA.113.302222","article-title":"Hyperglycemia-induced secretion of endothelial heparanase stimulates a vascular endothelial growth factor autocrine network in cardiomyocytes that promotes recruitment of lipoprotein lipase","volume":"33","author":"D Zhang","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"04","key":"ref97","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF00400234","article-title":"Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus","volume":"36","author":"F Wasty","year":"1993","journal-title":"Diabetologia"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2337\/diab.31.5.418","article-title":"35S-glycosaminoglycan and 35S-glycopeptide metabolism by diabetic glomeruli and aorta","volume":"31","author":"D M Brown","year":"1982","journal-title":"Diabetes"},{"issue":"05","key":"ref99","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.matbio.2013.03.001","article-title":"Heparanase: multiple functions in inflammation, diabetes and atherosclerosis","volume":"32","author":"I Vlodavsky","year":"2013","journal-title":"Matrix Biol"},{"issue":"02","key":"ref100","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/ATVBAHA.112.254961","article-title":"Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression","volume":"33","author":"M Blich","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"01","key":"ref101","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2012.09.030","article-title":"Increased expression of heparanase in symptomatic carotid atherosclerosis","volume":"226","author":"C Osterholm","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.atherosclerosis.2018.12.027","article-title":"Dual roles of heparanase in human carotid plaque calcification","volume":"283","author":"S Aldi","year":"2019","journal-title":"Atherosclerosis"},{"issue":"11","key":"ref103","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3324\/haematol.2010.023713","article-title":"Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII","volume":"95","author":"Y Nadir","year":"2010","journal-title":"Haematologica"},{"issue":"03","key":"ref104","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1161\/hq0302.105378","article-title":"Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis","volume":"22","author":"V V Kunjathoor","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"02","key":"ref105","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1194\/jlr.M053017","article-title":"The glycosylation-dependent interaction of perlecan core protein with LDL: implications for atherosclerosis","volume":"56","author":"Y X Xu","year":"2015","journal-title":"J Lipid Res"},{"issue":"01","key":"ref106","first-page":"43","article-title":"Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation","volume":"103","author":"K Tran-Lundmark","year":"2008","journal-title":"Circ Res"},{"issue":"01","key":"ref107","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbagen.2004.02.005","article-title":"High-glucose-induced structural changes in the heparan sulfate proteoglycan, perlecan, of cultured human aortic endothelial cells","volume":"1672","author":"C A Vogl-Willis","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"05","key":"ref108","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.ATV.0000126375.60073.74","article-title":"High glucose-induced alterations in subendothelial matrix perlecan leads to increased monocyte binding","volume":"24","author":"C A Vogl-Willis","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"02","key":"ref109","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/stem.2506","article-title":"Advanced glycation endproducts impair endothelial progenitor cell migration and homing via syndecan 4 shedding","volume":"35","author":"J Xie","year":"2017","journal-title":"Stem Cells"},{"issue":"04","key":"ref110","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0022-2275(20)32571-2","article-title":"Chylomicron remnant uptake is regulated by the expression and function of heparan sulfate proteoglycan in hepatocytes","volume":"39","author":"B J Zeng","year":"1998","journal-title":"J Lipid Res"},{"issue":"11","key":"ref111","first-page":"3236","article-title":"Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice","volume":"119","author":"K I Stanford","year":"2009","journal-title":"J Clin Invest"},{"issue":"02","key":"ref112","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00592-010-0216-2","article-title":"Negative correlation between serum syndecan-1 and apolipoprotein A1 in patients with type 2 diabetes mellitus","volume":"50","author":"J B Wang","year":"2013","journal-title":"Acta Diabetol"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2013.01.015","article-title":"Role of heparan sulfate in ocular diseases","volume":"110","author":"P J Park","year":"2013","journal-title":"Exp Eye Res"},{"issue":"09","key":"ref114","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1007\/s00125-008-0989-9","article-title":"Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy","volume":"51","author":"R Sim\u00f3","year":"2008","journal-title":"Diabetologia"},{"issue":"09","key":"ref115","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1167\/iovs.11-7909","article-title":"Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera","volume":"52","author":"S J Clark","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"18","key":"ref116","doi-asserted-by":"crossref","first-page":"8970","DOI":"10.1128\/JVI.00296-06","article-title":"Role for 3-O-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts","volume":"80","author":"V Tiwari","year":"2006","journal-title":"J Virol"},{"issue":"05","key":"ref117","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1167\/iovs.14-15341","article-title":"Loss of corneal epithelial heparan sulfate leads to corneal degeneration and impaired wound healing","volume":"56","author":"V J Coulson-Thomas","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref118","first-page":"1125","article-title":"Age-dependent alteration of intraocular soluble heparan sulfate levels and its implications for proliferative diabetic retinopathy","volume":"19","author":"K M Nishiguchi","year":"2013","journal-title":"Mol Vis"},{"issue":"02","key":"ref119","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1076\/ceyr.16.2.127.5089","article-title":"Heparan sulfate proteoglycan synthesis and its expression are decreased in the retina of diabetic rats","volume":"16","author":"J S Bollineni","year":"1997","journal-title":"Curr Eye Res"},{"issue":"10","key":"ref120","doi-asserted-by":"crossref","first-page":"e13493","DOI":"10.1371\/journal.pone.0013493","article-title":"Regulation of pathologic retinal angiogenesis in mice and inhibition of VEGF-VEGFR2 binding by soluble heparan sulfate","volume":"5","author":"K M Nishiguchi","year":"2010","journal-title":"PLoS One"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3389\/fimmu.2020.00769","article-title":"Proteoglycans in obesity-associated metabolic dysfunction and meta-inflammation","volume":"11","author":"A R Pessentheiner","year":"2020","journal-title":"Front Immunol"},{"issue":"02","key":"ref122","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/ATVBAHA.114.304720","article-title":"Syndecan-1 modulates the motility and resolution responses of macrophages","volume":"35","author":"J Angsana","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"09","key":"ref123","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/db11-1395","article-title":"Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine","volume":"61","author":"S Ussar","year":"2012","journal-title":"Diabetes"},{"issue":"06","key":"ref124","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00592-014-0652-5","article-title":"Glypican-4 is increased in human subjects with impaired glucose tolerance and decreased in patients with newly diagnosed type 2 diabetes","volume":"51","author":"K Li","year":"2014","journal-title":"Acta Diabetol"},{"issue":"01","key":"ref125","doi-asserted-by":"crossref","first-page":"7766","DOI":"10.1038\/s41598-018-25635-x","article-title":"Perlecan, a heparan sulfate proteoglycan, regulates systemic metabolism with dynamic changes in adipose tissue and skeletal muscle","volume":"8","author":"Y Yamashita","year":"2018","journal-title":"Sci Rep"},{"issue":"01","key":"ref126","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI32335","article-title":"Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function","volume":"118","author":"L Bode","year":"2008","journal-title":"J Clin Invest"},{"issue":"03","key":"ref127","doi-asserted-by":"crossref","first-page":"G241","DOI":"10.1152\/ajpgi.00480.2012","article-title":"Heparan sulfate on intestinal epithelial cells plays a critical role in intestinal crypt homeostasis via Wnt\/\u03b2-catenin signaling","volume":"305","author":"S Yamamoto","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"03","key":"ref128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4239\/wjd.v4.i3.51","article-title":"Gastrointestinal complications of diabetes mellitus","volume":"4","author":"B Krishnan","year":"2013","journal-title":"World J Diabetes"},{"issue":"12","key":"ref129","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1007\/s00125-006-0465-3","article-title":"Increased intestinal permeability precedes clinical onset of type 1 diabetes","volume":"49","author":"E Bosi","year":"2006","journal-title":"Diabetologia"},{"issue":"06","key":"ref130","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/jcmm.12523","article-title":"High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression","volume":"19","author":"Q Qing","year":"2015","journal-title":"J Cell Mol Med"},{"issue":"02","key":"ref131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21020679","article-title":"Review of alterations in perlecan-associated vascular risk factors in dementia","volume":"21","author":"A L Trout","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"04","key":"ref132","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00592-010-0218-0","article-title":"Encephalopathies: the emerging diabetic complications","volume":"47","author":"A A Sima","year":"2010","journal-title":"Acta Diabetol"},{"issue":"01","key":"ref133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-35976-2","article-title":"Brain-specific ultrastructure of capillary endothelial glycocalyx and its possible contribution for blood brain barrier","volume":"8","author":"Y Ando","year":"2018","journal-title":"Sci Rep"},{"issue":"02","key":"ref134","first-page":"125","article-title":"Diabetes mellitus and blood-brain barrier dysfunction: an overview","volume":"2","author":"S Prasad","year":"2014","journal-title":"J Pharmacovigil"},{"issue":"01","key":"ref135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bbrc.2007.01.137","article-title":"The role of endothelial glycocalyx components in mechanotransduction of fluid shear stress","volume":"355","author":"M Y Pahakis","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"04","key":"ref136","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s11011-017-0019-z","article-title":"Brain heparan sulphate proteoglycans are altered in developing foetus when exposed to in-utero hyperglycaemia","volume":"32","author":"M S Sandeep","year":"2017","journal-title":"Metab Brain Dis"},{"issue":"03","key":"ref137","doi-asserted-by":"crossref","first-page":"e34313","DOI":"10.1371\/journal.pone.0034313","article-title":"Heparanase affects food intake and regulates energy balance in mice","volume":"7","author":"L Karlsson-Lindahl","year":"2012","journal-title":"PLoS One"},{"issue":"09","key":"ref138","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s00125-008-1085-x","article-title":"Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis","volume":"51","author":"H F Irving-Rodgers","year":"2008","journal-title":"Diabetologia"},{"issue":"01","key":"ref139","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1172\/JCI46177","article-title":"Heparan sulfate and heparanase play key roles in mouse \u03b2 cell survival and autoimmune diabetes","volume":"122","author":"A F Ziolkowski","year":"2012","journal-title":"J Clin Invest"},{"issue":"02","key":"ref140","doi-asserted-by":"crossref","first-page":"e0191360","DOI":"10.1371\/journal.pone.0191360","article-title":"Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humans","volume":"13","author":"C J Simeonovic","year":"2018","journal-title":"PLoS One"},{"issue":"01","key":"ref141","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1681\/ASN.2011040378","article-title":"Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy","volume":"23","author":"D K Packham","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"ref142","first-page":"6275","article-title":"Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review","volume":"9","author":"R Li","year":"2015","journal-title":"Drug Des Devel Ther"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1724118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T01:27:38Z","timestamp":1617672458000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1724118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":142,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2021,4,1]]},"published-print":{"date-parts":[[2021,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1724118","relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}